Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance

Standard fractionated radiotherapy for the treatment of cancer consists of daily irradiation of 2-Gy X-rays, 5 days a week for 5–8 weeks. To understand the characteristics of radioresistant cancer cells and to develop more effective radiotherapy, we established a series of novel, clinically relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukumoto, Motoi, Amanuma, Tatsuya, Kuwahara, Yoshikazu, Shimura, Tsutomu, Suzuki, Masatoshi, Mori, Shiro, Kumamoto, Hiroyuki, Saito, Yohei, Ohkubo, Yasuhito, Duan, Zhenfeng, Sano, Kenji, Oguchi, Tomohiro, Kainuma, Kazuyuki, Usami, Shinichi, Kinoshita, Kengo, Lee, Inchul, Fukumoto, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462352/
https://www.ncbi.nlm.nih.gov/pubmed/25098609
http://dx.doi.org/10.1111/cas.12489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462352/
https://www.ncbi.nlm.nih.gov/pubmed/25098609
http://dx.doi.org/10.1111/cas.12489

Ejemplares similares